Evidence map›Paper›PMID 39277586›Full record

ReviewLight, science & applications2024

Towards next-generation diagnostic pathology: AI-empowered label-free multiphoton microscopy.

Shu Wang, Junlin Pan, Xiao Zhang, Yueying Li, Wenxi Liu, Ruolan Lin, Xingfu Wang, Deyong Kang, Zhijun Li, Feng Huang and 2 more

Abstract readReview
In one paragraph

Review in Light, science & applications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Second-harmonic generation in NbOINanophotonics (Berlin, Germany) · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Shu WangSchool of Mechanical Engineering and Automation, Fuzhou University, Fuzhou, 350108, China.ORCID http://orcid.org/0000-0003-0829-5694
Junlin PanSchool of Mechanical Engineering and Automation, Fuzhou University, Fuzhou, 350108, China.
Xiao ZhangCollege of Computer and Data Science, Fuzhou University, Fuzhou, 350108, China.
Yueying LiSchool of Mechanical Engineering and Automation, Fuzhou University, Fuzhou, 350108, China.
Wenxi LiuCollege of Computer and Data Science, Fuzhou University, Fuzhou, 350108, China.
Ruolan LinDepartment of Radiology, Fujian Medical University Union Hospital, Fuzhou, 350001, China.
Xingfu WangDepartment of Pathology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China.
Deyong KangDepartment of Pathology, Fujian Medical University Union Hospital, Fuzhou, 350001, China.
Zhijun LiKey Laboratory of OptoElectronic Science and Technology for Medicine of Ministry of Education, Fujian Provincial Key Laboratory of Photonics Technology, Fujian Normal University, Fuzhou, 350007, China.
Feng HuangSchool of Mechanical Engineering and Automation, Fuzhou University, Fuzhou, 350108, China. huangf@fzu.edu.cn.ORCID http://orcid.org/0000-0003-4652-4312
Liangyi ChenNew Cornerstone Laboratory, State Key Laboratory of Membrane Biology, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Institute of Molecular Medicine, National Biomedical Imaging Center, School of Future Technology, Peking University, Beijing, 100091, China. lychen@pku.edu.cn.ORCID http://orcid.org/0000-0003-1270-7321
Jianxin ChenKey Laboratory of OptoElectronic Science and Technology for Medicine of Ministry of Education, Fujian Provincial Key Laboratory of Photonics Technology, Fujian Normal University, Fuzhou, 350007, China. chenjianxin@fjnu.edu.cn.ORCID http://orcid.org/0000-0001-8519-4462

Funding

National Natural Science Foundation of China (National Science Foundation of China) 32227802National Natural Science Foundation of China (National Science Foundation of China) 62005049National Natural Science Foundation of China (National Science Foundation of China) 81925022National Natural Science Foundation of China (National Science Foundation of China) 82171991National Natural Science Foundation of China (National Science Foundation of China) T2288102
6 · The paper itself

Abstract

Diagnostic pathology, historically dependent on visual scrutiny by experts, is essential for disease detection. Advances in digital pathology and developments in computer vision technology have led to the application of artificial intelligence (AI) in this field. Despite these advancements, the variability in pathologists' subjective interpretations of diagnostic criteria can lead to inconsistent outcomes. To meet the need for precision in cancer therapies, there is an increasing demand for accurate pathological diagnoses. Consequently, traditional diagnostic pathology is evolving towards "next-generation diagnostic pathology", prioritizing on the development of a multi-dimensional, intelligent diagnostic approach. Using nonlinear optical effects arising from the interaction of light with biological tissues, multiphoton microscopy (MPM) enables high-resolution label-free imaging of multiple intrinsic components across various human pathological tissues. AI-empowered MPM further improves the accuracy and efficiency of diagnosis, holding promise for providing auxiliary pathology diagnostic methods based on multiphoton diagnostic criteria. In this review, we systematically outline the applications of MPM in pathological diagnosis across various human diseases, and summarize common multiphoton diagnostic features. Moreover, we examine the significant role of AI in enhancing multiphoton pathological diagnosis, including aspects such as image preprocessing, refined differential diagnosis, and the prognostication of outcomes. We also discuss the challenges and perspectives faced by the integration of MPM and AI, encompassing equipment, datasets, analytical models, and integration into the existing clinical pathways. Finally, the review explores the synergy between AI and label-free MPM to forge novel diagnostic frameworks, aiming to accelerate the adoption and implementation of intelligent multiphoton pathology systems in clinical settings.

Identifiers

PMID39277586
PMCPMC11401902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.